Antiplatelet agents for preventing pre-eclampsia and its complications-Reference-Cited by-同舟云学术

Antiplatelet agents for preventing pre-eclampsia and its complications

Published:2007-04-18 Issue: Volume: Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Duley Lelia¹,Henderson-Smart David J²,Meher Shireen³,King James F⁴

Affiliation:

1. University of Leeds; Centre for Epidemiology and Biostatistics; Bradford Institute for Health Research Bradford Royal Infirmary, Duckworth Lane Bradford West Yorkshire UK BD9 6RJ

2. Queen Elizabeth II Research Institute; NSW Centre for Perinatal Health Services Research; Building DO2 University of Sydney Sydney NSW Australia 2006

3. The University of Liverpool; School of Reproductive and Developmental Medicine, Division of Perinatal and Reproductive Medicine; First Floor, Liverpool Women's NHS Foundation Trust Crown Street Liverpool UK L8 7SS

4. Royal Women's Hospital; Department of Perinatal Medicine; Carlton Victoria Australia 3053

Publisher

Wiley

Subject

Pharmacology (medical)

Reference295 articles.

1. Trudinger BJ Cook CM Connelly AJ Giles WB Thompson RS Aspirin improves fetal weight in placental insufficiency Proceedings of 8th Annual Meeting of the Society of Perinatal Obstetricians; 1988 February 3-6; Las Vegas, Nevada, USA 1988 10

2. Low-dose aspirin improves fetal weight in umbilical placental insufficiency;Trudinger;Lancet,1988

3. Low-dose aspirin therapy improves fetal weight in umbilical placental insufficiency;Trudinger;American Journal of Obstetrics and Gynecology,1988

4. Michael CA Seville P Wadeisha P Walters BNJ Randomised double blind placebo controlled trial of aspirin in the prevention of pre-eclampsia Proceedings of 7th World Congress of Hypertension in Pregnancy; 1990 October; Perugia, Italy 1990 73

5. Low-dose aspirin in the prevention of pre-eclampsia: current evaluation;Michael,1992

Cited by 471 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Placental growth factor at 24–28 weeks for aspirin discontinuation in pregnancies at high risk for preterm preeclampsia: Post hoc analysis of StopPRE trial;Acta Obstetricia et Gynecologica Scandinavica;2024-08-22

2. Potential epigenetic markers of clinical diagnostics/therapeutic targets in preeclampsia;Epigenomics;2024-08-08

3. Stillbirth: we can do better;American Journal of Obstetrics and Gynecology;2024-08

4. Can short‐ and long‐term maternal and infant risks linked to hypertension and diabetes during pregnancy be reduced by therapy?;Journal of Internal Medicine;2024-07-24

5. Evidence‐based interventions to address persistent maternal mortality rates;Ultrasound in Obstetrics & Gynecology;2024-07-15